Dr. Jonathan S. Deitch, MD

Dr. Deitch practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Deitch's NPI, 1679551469, was assigned on January 3, 2006. Dr. Deitch graduated from New York Medical College in 1991. Dr. Deitch holds Texas license T3610.

Dr. Deitch's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Deitch's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Deitch is also affiliated with Texas Health Cleburne. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Deitch to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deitch practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Deitch's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Deitch's licenses on file in 2 states: Texas and New York.

CMS data shows 549 Medicare services from Dr. Deitch across 14 procedure codes in 2024, for 315 Medicare patients. Medicare paid $65,175 for them.

CMS counts 315 Medicare patients who saw Dr. Deitch in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deitch's median patient age at 70, with 43% women.

In 2024, Dr. Deitch wrote 56 Medicare Part D claims for 29 patients. 89% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $156 in total drug cost. In 2016, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Deitch for performance year 2024, reported individually. Dr. Deitch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of leg revascularization (restoring blood flow) by Dr. Deitch, more than 87% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Deitch, published from 2011 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Endovascular Procedures, Peripheral Arterial Disease and Vascular Patency. Dr. Deitch has published most often in Ann Vasc Surg. Dr. Deitch's most frequent co-authors are Jonathan Andrew Schor, MD, Amandeep Singh Juneja, MBBS and Ritu Aparajita, MD.

Dmand AI links Dr. Deitch to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome and Venous Insufficiency.

CMS Open Payments shows 264 general payments to Dr. Deitch from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. W. L. Gore & Associates, Inc. paid the most, $5,722.

Dr. Deitch graduated from New York Medical College in 1991.